An amino acid sequence from the C-terminus of human Rap1-interacting adaptor molecule (EQDFMSDLMKALQKKRGNVS) was used as the immunogen for this RIAM antibody.
APBB1IP
Reaktivität: Human
ELISA, IHC (fro), IHC (p), IF (cc), IF (p)
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
The stated application concentrations are suggested starting amounts. Titration of the RIAM antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 0.5-1 μg/mL,IHC (Paraffin): 0.5-1 μg/mL,IHC (Frozen): 0.5-1 μg/mL,Immunocytochemistry: 0.5-1 μg/mL
Beschränkungen
Nur für Forschungszwecke einsetzbar
Buffer
0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
Lagerung
-20 °C
Informationen zur Lagerung
After reconstitution, the RIAM antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.
Target
Amyloid beta (A4) Precursor Protein-Binding, Family B, Member 1 Interacting Protein (APBB1IP)
zgc:63968 antikoerper, apbb1ip antikoerper, MGC80693 antikoerper, APBB1IP antikoerper, INAG1 antikoerper, PREL1 antikoerper, RARP1 antikoerper, RIAM antikoerper, 9930118P07Rik antikoerper, Prp48 antikoerper, amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein antikoerper, amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein S homeolog antikoerper, amyloid beta precursor protein binding family B member 1 interacting protein antikoerper, amyloid beta A4 precursor protein-binding family B member 1-interacting protein antikoerper, apbb1ip antikoerper, apbb1ip.S antikoerper, APBB1IP antikoerper, LOC707383 antikoerper, LOC100439620 antikoerper, LOC100598478 antikoerper, Apbb1ip antikoerper
Hintergrund
RIAM (Rap1-interacting adaptor molecule), also called RARP1 and APBB1-Interacting Protein, is a protein that in humans is encoded by the APBB1IP gene. By genomic sequence analysis, Lafuente et al.(2004) mapped the gene to chromosome 10p12.1. Using promoter-reporter gene assays, Inagaki et al.(2003) found that RIAM suppressed transcription from AP1 and SRE sites, but not CRE sites, in all cell lines examined. The proline-rich regions of RIAM suppressed AP1 transactivation. Lafuente et al.(2004) found that the protein interacted with profilin and VASP, molecules that regulate actin dynamics, as well as with RAP1-GTP.